Qureator, Inc.
San Diego, CA, United States qureator.com From their website, Nov 2026
Work here? Claim this listing
About
Qureator, Inc. develops humanized tissue and organ-on-a-chip disease models for drug discovery and therapy evaluation. It works with biotech and drug development teams seeking human-relevant testing for cancers, immunotherapy, AMD, DILI, and blood-brain barrier applications. The company is headquartered in San Diego, California, with a site in Seoul, South Korea.
Services
Commissioned Research
Custom research services using its humanized tissue and Curiochips platform to evaluate treatments and disease biology.
Disease model partnership
Partnership-based development of disease models for evaluating therapies in human-relevant systems.
Therapy co-development
Collaborative development of therapies using Curiochips and human tissue models.
Curiochips-enabled disease models
3D organ-on-a-chip human disease models designed to recreate aspects of human biology and disease.
Human tissue screening
High-throughput screening of treatments with human tissue using the HT-MPS platform.
QuriCore AI analysis
AI-based prediction and data analysis for target identification, synergistic combinations, efficacy, dose prediction, and biomarker analysis.
Capabilities
- Assays and studies
- Small molecules
- Disease modeling
- High-throughput screening
- Target validation
- Combination testing
- Dose-response analysis
9 more
- Biochemical analysis
- Image feature extraction
- Multimodal analysis
- Biomarker analysis
- Patient stratification
- Clinical outcome prediction
- Multimodal measurements
- 3D image analysis
- Combination screening
- Scale and capacity
- High throughput
- HT-MPS platform
- Therapeutic areas
- Cancer metastasis
- Cancer vTIME for immunotherapy
- Age-related macular degeneration (AMD)
- Drug induced liver injury (DILI)
- Blood-brain barrier (BBB)
- Cancer
- Immunotherapy
- Blood brain barrier (BBB)
Instruments and platforms
- Curiochips
- QuriCore AI
- Graph neural networks
- 3D image analysis
Modalities and species
- Modalities
- Small molecule
- Antibody
- Cell therapy
- Gene editing
- Species and models
- Human cells
- Patient-derived data
- Patient samples
- Primary cells
- Tumor organoid
- Stromal cells
3 more
- Endothelial cells
- Immune cells
- Epithelial cells
Industries served
- Biotech
- Drug discovery
Details
- Founded
- 2020
- Ownership
- Small business · Minority-owned, as registered with SAM.gov or stated on their site
- Address
- 7094 Miratech Drive, Suite 110 San Diego, CA 92121, USA
- Sites
- Seoul, South Korea